Noramco - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeNoramco
Noramco logo

Noramco

0 followers

About Noramco

Noramco is a specialty pharmaceutical company focused on active pharmaceutical ingredient (API) development and manufacturing. It supports the advancement of opioid and non-opioid products, with expertise in controlled substances from development through large-scale supply and formulation-ready particle size options. Headquartered in Delaware with global operations, Noramco emphasizes DEA-compliant production, high-purity APIs, and regulatory readiness to serve the pharmaceutical industry. The company positions itself as a leader in addiction treatment and abuse prevention through its nal-family compounds and ADHD-related APIs.

Recent News

No recent news for this company.

Recent Deals

Key Team Members

Lee Karras

Group Chief Executive

Jim Mish

CEO

Alan Majewski

President and Group Chief Financial Officer

Charlie Enzinger

Senior Vice President, Integrated Supply Chain

Bill Grubb

Vice President, Business Development and Innovation

Key Facts

HQ Location

Wilmington, United States

Founded

1979

Employees

201 - 500

Status

Private

Website

https://noramco.com